4.6 Article

Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening

Journal

ACS CHEMICAL BIOLOGY
Volume 3, Issue 8, Pages 486-498

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/cb800051m

Keywords

-

Funding

  1. National Institutes of Health [U54 MH074404-01]
  2. MAID

Ask authors/readers for more resources

We have studied the sphingosine 1-phosphate (S1P) receptor system to better understand why certain molecular targets within a closely related family are much more tractable when identifying compelling chemical leads. Five medically important G-protein-coupled receptors for Sip regulate heart rate, coronary artery caliber, endothelial barrier integrity, and lymphocyte trafficking. Selective S1P receptor agonist probes would be of great utility to study receptor subtype-specific function. Through systematic screening of the same libraries, we identified novel selective agonist chemotypes for each of the S1P(1) and S1P(3) receptors. Ultrahigh-throughput screening (uHTS) for S1P(1) was more effective than that for S1P(3), with many selective, low nanomolar hits of proven mechanism emerging. Receptor structure modeling and ligand docking reveal differences between the receptor binding pockets, which are the basis for subtype selectivity. Novel selective agonists interact primarily in the hydrophobic pocket of the receptor in the absence of headgroup interactions. Chemistry-space and shape-based analysis of the screening libraries in combination with the binding models explain the observed differential hit rates and enhanced efficiency for lead discovery for S1P(1) versus S1P(3) in this closely related receptor family.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Novel Selective Allosteric and Bitopic Ligands for the S1P3 Receptor

Euijung Jo, Barun Bhhatarai, Emanuela Repetto, Miguel Guerrero, Sean Riley, Steven J. Brown, Yasushi Kohno, Edward Roberts, Stephan C. Schuerer, Hugh Rosen

ACS CHEMICAL BIOLOGY (2012)

Article Multidisciplinary Sciences

Crystal Structure of a Lipid G Protein-Coupled Receptor

Michael A. Hanson, Christopher B. Roth, Euijung Jo, Mark T. Griffith, Fiona L. Scott, Greg Reinhart, Hans Desale, Bryan Clemons, Stuart M. Cahalan, Stephan C. Schuerer, M. Germana Sanna, Gye Won Han, Peter Kuhn, Hugh Rosen, Raymond C. Stevens

SCIENCE (2012)

Article Multidisciplinary Sciences

High-Resolution Global Maps of 21st-Century Forest Cover Change

M. C. Hansen, P. V. Potapov, R. Moore, M. Hancher, S. A. Turubanova, A. Tyukavina, D. Thau, S. V. Stehman, S. J. Goetz, T. R. Loveland, A. Kommareddy, A. Egorov, L. Chini, C. O. Justice, J. R. G. Townshend

SCIENCE (2013)

Article Pharmacology & Pharmacy

3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation

Yan-Rou Tsai, Dong Seok Kim, Shih-Chang Hsueh, Kai-Yun Chen, John Chung-Che Wu, Jia-Yi Wang, Yi-Syue Tsou, Inho Hwang, Yukyung Kim, Dayeon Gil, Eui Jung Jo, Baek-Soo Han, David Tweedie, Daniela Lecca, Michael T. Scerba, Warren R. Selman, Barry J. Hoffer, Nigel H. Greig, Yung-Hsiao Chiang

Summary: The immunomodulatory drug pomalidomide and its derivatives 3,6'-DP and 1,6'-DP have shown promising anti-inflammatory effects in a rat stroke model. These compounds may have the potential to be valuable therapies for stroke and should be further developed.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo

M. Germana Sanna, Sheng-Kai Wang, Pedro J. Gonzalez-Cabrera, Anthony Don, David Marsolais, Melanie P. Matheu, Sindy H. Wei, Ian Parker, Euijung Jo, Wei-Chieh Cheng, Michael D. Cahalan, Chi-Huey Wong, Hugh Rosen

NATURE CHEMICAL BIOLOGY (2006)

Article Immunology

Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses

SH Wei, H Rosen, MP Matheu, MG Sanna, SK Wang, EJ Jo, CH Wong, I Parker, MD Cahalan

NATURE IMMUNOLOGY (2005)

Article Biochemistry & Molecular Biology

S1P1-selective in vivo-active agonists from high-throughput screening:: Off-the-shelf chemical probes of receptor interactions, signaling, and fate

EJ Jo, G Sanna, PJ Gonzalez-Cabrera, S Thangada, G Tigyi, DA Osborne, T Hla, AL Parrill, H Rosen

CHEMISTRY & BIOLOGY (2005)

Article Biochemistry & Molecular Biology

α-synuclein-synaptosomal membrane interactions -: Implications for fibrillogenesis

E Jo, AA Darabie, K Han, A Tandon, PE Fraser, J McLaurin

EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate

MG Sanna, JY Liao, EJ Jo, C Alfonso, MY Ahn, MS Peterson, B Webb, S Lefebvre, J Chun, N Gray, H Rosen

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Defective membrane interactions of familial Parkinson's disease mutant A30P α-synuclein

EJ Jo, N Fuller, RP Rand, P St George-Hyslop, PE Fraser

JOURNAL OF MOLECULAR BIOLOGY (2002)

Article Biochemistry & Molecular Biology

α-synuclein membrane interactions and lipid specificity

EJ Jo, J McLaurin, CM Yip, P St George-Hyslop, PE Fraser

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

No Data Available